Lv5
1028 积分 2025-06-06 加入
聚焦危重症患者连续性肾脏替代治疗的容量管理
21天前
已完结
Pancreatic cancer
1个月前
已完结
Therapeutic cancer vaccines in pancreatic cancer
1个月前
已关闭
Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group
1个月前
已完结
Adjuvant nab-Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
1个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
2个月前
已完结
Gastric Cancer: A Review
3个月前
已完结
Daraxonrasib in Previously Treated Advanced RAS -Mutated Pancreatic Cancer
3个月前
已完结
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
6个月前
已完结
Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial
6个月前
已完结
皖公网安备34019202002308
